Abstract: Pan-cancer intratumour heterogeneity (ITH) characteristics and their relationship with clinical prognosis have not been fully investigated. In this study ...
TORONTO, March 26, 2026 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (EDT:CA), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced its financial ...
TORONTO, March 26, 2026 (GLOBE NEWSWIRE)-- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, ...
Latest commit History History 502 lines (400 loc) · 17.8 KB PCNtoolkit / doc / pages / tutorials / 07_model_comparison.rst ...
Key 2026 clinical milestones: The recurrent cSCC pivotal trial is nearing completion with last patient treatments expected imminently and topline data planned for H2 2026, while a GBM pilot safety ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果